Diabetes Mellitus, Type 2 Clinical Trial
Official title:
Occupational Therapy Led Interdisciplinary Diabetes Self-Management Program
This study proposes to introduce an outpatient Occupational Therapy (OT)-led diabetes intervention program. OTs with training in diabetes self-management modules that address physical, social, emotional, and systemic factors that influence health. Patients receiving outpatient OT services for development of diabetes self-management skills will be seen for approximately 8 forty five-minute to one-hour sessions over 6 months. OTs will communicate with other interdisciplinary care team members using Electronic Health Record (EHR) messaging, phone calls, and in-person communication as needed. There will be at minimum a monthly consult meeting with a doctor of psychology (Psy D), registered dietitian (RD), social worker (SW), and pharmacist (PharmD), and the primary care medical team will be provided with monthly progress notes. The investigators hypothesize that participants demonstrate improved blood sugar levels, improved ability to take medications as directed, increases in overall sense of physical, mental, and social health, and positive changes in their self-efficacy related to diabetes self-management. The investigators also hypothesize that OT visits will be reimbursed by insurers more than 50% of all billed visits.
Effective interventions to support patients' diabetes management are urgently needed to
curtail the growing financial and human cost of diabetes. However, sustainable solutions to
this health challenge have been elusive due to the intrinsic and extrinsic barriers patients
face when attempting to incorporate necessary health behaviors into their daily routines
(e.g., dietary changes, physical activity, medication management, blood glucose monitoring,
and stress management). The focus of occupational therapy (OT) is to work with patients
within the context of their daily lives. OTs identify current patient roles (work, family,
community), habits, and routines, then work with the patient to identify and address barriers
to diabetes self-management within these aspects of their daily lives. Within OT, an
intervention approach informed by Lifestyle Redesign (LR) has been shown to be effective at
improving diabetes-related health outcomes among people with diabetes. This study proposes to
introduce an OT- led diabetes intervention program into an outpatient OT clinic. The
intervention is an interdisciplinary team approach as the intervention is informed and
monitored by the interdisciplinary team members, who are part of the planning process, and
who will participate in regular review of the intervention and the patient needs. With OT
leading the team to address barriers to lifestyle modification, the primary care medical team
will continue to oversee the overall health care of the patient. The OT will communicate
regularly with the primary care team.
OTs with training in diabetes education will deliver the intervention to patients in the
study within the course of their typical work day at the OT clinic. Treatment activities and
materials will be delivered in English or Spanish, per patient preference as one of the OT
interventionists is fluent in Spanish. Patients receiving OT services for development of
diabetes self-management skills will be seen for approximately 8 forty five-minute to
one-hour sessions over 6 months. OT notes will be maintained within the Electronic Health
Record (EHR) as is standard practice at this clinic; the therapist will communicate with
other interdisciplinary care team members using EHR messaging, phone calls, and in-person
communication as needed. There will be at minimum a monthly consult meeting with a doctor of
psychology (Psy D), registered dietitian (RD), social worker (SW), and pharmacist (PharmD),
and the primary care medical team will be provided with monthly progress notes.
The intervention will be offered in a one-on-one direct therapy format. The intervention will
focus on lifestyle modification strategies that will improve the patient's diabetes
self-management skills. The intervention is organized into five modules that address:
- living with diabetes,
- strategies to communicate with healthcare providers to ensure patient needs are met,
- analyzing and modifying patient habits and routines to determine what changes they must
make to manage their diabetes,
- identify and use social supports to help manage diabetes
- strategies to reduce stress and depression, improve emotional well-being, and minimize
risk of diabetes burn-out (patient frustration with living with the disease)
Each patient receives an individually tailored combination of modules, and treatment
activities within each module as established through collaborative goal setting between the
patient and OT during the initial evaluation.
The investigators will analyze outcomes using descriptive analytics and paired t-tests to
test our hypotheses. The investigators will collect EHR data on HbA1c and compare pre/post
measures of the clinically relevant self-report surveys on diabetes self care, and barriers
to self-care and management (Diabetes Empowerment Scale, Medication Adherence Assessment
Scale, and the Canadian Occupational Performance Measure), physical, mental, and social
health (Patient-Reported Outcomes Measurement Information System® PROMIS-29). Changes in
HbA1c levels will be tracked by obtaining recent levels from the patient's primary care team.
With patients referred to the OT intervention who have not had an HbA1c within ≤4 weeks of
the initial referral date, the OT will consult with the primary care physician and determine
if an HbA1c level can be obtained as a part of their normal care. The investigators will
collect EHR data on follow-up HbA1c testing scores that are available within 12 weeks of the
8th OT visit and self-report surveys the day of 8th OT visit. If a patient has completed the
full intervention, the study staff will follow-up biweekly for no more than 3 months after
their initial visit, and attempt to collect self-report data up to 6 months after the final
visit to determine the sustainability of outcomes.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05666479 -
CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
|
||
| Completed |
NCT05647083 -
The Effect of Massage on Diabetic Parameters
|
N/A | |
| Active, not recruiting |
NCT05661799 -
Persistence of Physical Activity in People With Type 2 Diabetes Over Time.
|
N/A | |
| Completed |
NCT03686722 -
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetis and Pharmacodynamics of Metformin
|
Phase 1 | |
| Completed |
NCT02836704 -
Comparison of Standard vs Higher Starting Dose of Insulin Glargine in Chinese Patients With Type 2 Diabetes (Glargine Starting Dose)
|
Phase 4 | |
| Completed |
NCT01819129 -
Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT04562714 -
Impact of Flash Glucose Monitoring in People With Type 2 Diabetes Using Non-Insulin Antihyperglycemic Therapy
|
N/A | |
| Completed |
NCT02009488 -
Treatment Differences Between Canagliflozin and Placebo in Insulin Secretion in Subjects With Type 2 Diabetes Mellitus (T2DM)
|
Phase 1 | |
| Completed |
NCT05896319 -
Hyaluronic Acid Treatment of the Post-extraction Tooth Socket Healing in Subjects With Diabetes Mellitus Type 2
|
N/A | |
| Recruiting |
NCT05598203 -
Effect of Nutrition Education Groups in the Treatment of Patients With Type 2 Diabetes
|
N/A | |
| Completed |
NCT05046873 -
A Research Study Looking Into Blood Levels of Semaglutide and NNC0480-0389 When Given in the Same Injection or in Two Separate Injections in Healthy People
|
Phase 1 | |
| Terminated |
NCT04090242 -
Impact of App Based Diabetes Training Program in Conjunction With the BD Nano Pen Needle in People With T2 Diabetes
|
N/A | |
| Completed |
NCT04030091 -
Pulsatile Insulin Infusion Therapy in Patients With Type 1 and Type 2 Diabetes Mellitus
|
Phase 4 | |
| Completed |
NCT03604224 -
A Study to Observe Clinical Effectiveness of Canagliflozin 300 mg Containing Treatment Regimens in Indian Type 2 Diabetes Participants With BMI>25 kg/m^2, in Real World Clinical Setting
|
||
| Completed |
NCT03620357 -
Continuous Glucose Monitoring & Management In Type 2 Diabetes (T2D)
|
N/A | |
| Completed |
NCT01696266 -
An International Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes
|
||
| Completed |
NCT03620890 -
Detemir Versus NPH for Type 2 Diabetes Mellitus in Pregnancy
|
Phase 4 | |
| Withdrawn |
NCT05473286 -
A Research Study Looking at How Oral Semaglutide Works in People With Type 2 Diabetes in Germany, as Part of Local Clinical Practice
|
||
| Not yet recruiting |
NCT05029804 -
Effect of Walking Exercise Training on Adherence to Disease Management and Metabolic Control in Diabetes
|
N/A | |
| Completed |
NCT04531631 -
Effects of Dorzagliatin on 1st Phase Insulin and Beta-cell Glucose Sensitivity in T2D and Monogenic Diabetes
|
Phase 2 |